Related Experiment Video
Updated: Jun 27, 2026
Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells
Published on: December 9, 2016
Real-World Evidence on Hospitalization Costs of Pediatric Neoplasm Patients in China: Patterns, Trends, and
Peng Zhang1, Bifan Zhu2, Linan Wang2,3
1Shanghai University of Traditional Chinese Medicine, School of Nursing, Pudong District, Shanghai, China.
Insights
Pediatric neoplasm hospitalizations are costly, but overall costs decreased due to lower drug expenses. Key cost drivers include sex, insurance, and treatment type, highlighting the need for better insurance and equitable care.
Area of Science:
- Pediatric Oncology
- Health Economics
- Public Health
Background:
- Increasing incidence and economic burden of pediatric neoplasms in China.
- Limited real-world data on comprehensive hospitalization costs for pediatric neoplasms.
- Hospitalization expenses are a significant component of the economic impact of childhood cancers.
Purpose of the Study:
- To analyze hospitalization cost patterns and trends for pediatric neoplasms in Shanghai.
- To identify key factors influencing these costs using real-world data.
- To provide evidence for improving healthcare resource allocation and insurance policies.
Main Methods:
- Retrospective multicenter cohort study analyzing pediatric hospitalization data (2017-2023).
- Inclusion of children (≤18 years) with ICD-10 coded neoplasms and complications.
- Cost analysis using descriptive statistics and generalized linear models (GLMs) on discounted, US dollar-converted costs.
Main Results:
- Neoplasms accounted for 1.91% of pediatric hospitalizations, with significantly higher costs than non-neoplasm cases.
- Total neoplasm costs decreased by 26.88% (2017-2023), primarily due to a 52.87% drop in drug costs.
- Malignant neoplasms, particularly leukemia, incurred the highest costs; sex, insurance, pathology, surgery, length of stay, and hospital type were significant cost drivers.
Conclusions:
- Comprehensive insights into pediatric neoplasm hospitalization costs and trends are provided.
- Need for enhanced insurance coverage, early diagnosis, and equitable resource distribution to mitigate financial burdens.
- Findings support targeted interventions to reduce healthcare expenditure disparities in pediatric cancer care.
Background:
In China, the incidence and burden of pediatric neoplasms have been increasing, contributing to escalating healthcare expenditures and productivity losses, with hospitalization costs constituting a major component of the economic burden. However, evidence on the full spectrum of neoplasm-related hospitalization costs for pediatric patients remains limited, particularly from real-world longitudinal studies.
Methods:
This retrospective multicenter cohort study (2017-2023) analyzed pediatric hospitalization data in Shanghai by integrating data from two administrative databases. The study included all children aged ≤ 18 years hospitalized with ICD-10-coded benign and malignant neoplasms and related complications. Hospitalization costs were discounted to 2023 values, converted to US dollars, and analyzed using descriptive statistics and generalized linear models (GLMs) to identify influencing factors, including socioeconomic, clinical, and hospital-related variables.
Results:
Among 688,131 pediatric hospitalizations, 13,057 (1.91%) were for neoplasms. Neoplasm patients had significantly higher care intensity and hospitalization costs than nonneoplasm patients, with malignant neoplasms incurring the highest median costs. From 2017 to 2023, total costs for neoplasm patients declined by 26.88%, driven by a 52.87% reduction in drug costs, contrasting with rising costs for nonneoplasm patients. Leukemia was the most prevalent condition, while some rare but high-cost entities, such as secondary malignant neoplasms of the respiratory and digestive organs, were among the most expensive. GLM analysis identified sex, insurance type, pathology, surgical interventions, length of stay, and hospital characteristics as significant cost drivers.
Conclusion:
This study provides comprehensive evidence on hospitalization cost patterns, trends, and influencing factors for pediatric neoplasms. It highlights the need for enhanced insurance coverage, early diagnosis and treatment, and equitable resource allocation to reduce disparities.
